$73.35
▼ -0.0% Today
as of Aug 5, 16:48 ET
Last 30 days
Recent Press Releases & News
RBC Adjusts Price Target on Eastman Chemical to $74 From $69, Maintains Sector Perform Rating
EMN: Raising target price to $78.00
UBS Adjusts Price Target on Eastman Chemical to $92 From $89, Maintain Buy Rating
Overview
52-week range
$56
$83
63% of range
Avg surprise (last 2)
-3.0%
Avg reaction (last 1)
+2.5%
100% positive
Latest IV / EM
37%
EM ±6.2% · $75 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Mar 31, 2026 | Mar 2026 | $0.93 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $0.40 | — | — | — | — | financials |
| Thu Jul 31, 2025 | Jun/2025 | $1.60 | $1.72 | -7.0% | — | — | earnings |
| Thu Apr 24, 2025 | Mar/2025 | $1.91 | $1.89 | +1.1% | — | +2.5% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $1.53 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $1.94 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $1.39 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $1.49 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $2.27 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.18B | — | $2.20B | $2.29B | $2.29B | — | $2.46B | $2.36B |
| Cost of revenue | $1.75B | — | $1.77B | $1.78B | $1.72B | — | $1.86B | $1.76B |
| Gross profit | $431M | — | $433M | $506M | $567M | — | $605M | $599M |
| Operating income | — | — | — | — | — | — | — | — |
| Net income | $107M | — | $47M | $140M | $182M | — | $180M | $230M |
| EPS (diluted) | $0.93 | — | $0.40 | $1.20 | $1.57 | — | $1.53 | $1.94 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | — | — | — | — | — | — | — | — |
| Inventory | $2.08B | $1.98B | $1.94B | $2.15B | $2.12B | $1.99B | $1.90B | $1.90B |
| Total current assets | $4.06B | $3.65B | $3.79B | $4.02B | $3.90B | $4.10B | $3.94B | $3.84B |
| Total assets | $15.22B | $14.86B | $14.98B | $15.22B | $14.97B | $15.21B | $15.06B | $14.95B |
| Long-term debt | $4.45B | $4.20B | $4.79B | $4.78B | $4.74B | $4.57B | $4.61B | $4.34B |
| Total liabilities | $9.14B | $8.82B | $9.14B | $9.31B | $9.03B | $9.36B | $9.33B | $9.25B |
| Total equity | $6.01B | $5.96B | $5.77B | $5.83B | $5.87B | $5.78B | $5.65B | $5.63B |